Alexion Secures Patent for Anti-CD200 Monoclonal Antibody for Treatment of Cancer.(Disease/Disorder overview): An article from: BIOTECH Patent News

This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on July 1, 2008. The length of the article is 568 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Alexion Secures Patent for Anti-CD200 Monoclonal Antibody for Treatment of Cancer.(Disease/Disorder overview)
Author: Gale Reference Team
Publication:BIOTECH Patent News (Newsletter)
Date: July 1, 2008
Publisher: Biotech Patent News
Volume: 22 Issue: 7

Article Type: Disease/Disorder overview

Distributed by Gale, a part of Cengage Learning